Intuitive Surgical, Inc. $ISRG Stock Sold by R Squared Ltd

R Squared Ltd trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,946 shares of the medical equipment provider’s stock after selling 2,990 shares during the quarter. R Squared Ltd’s holdings in Intuitive Surgical were worth $791,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical in the 2nd quarter valued at approximately $1,335,753,000. Arrowstreet Capital Limited Partnership increased its stake in Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares in the last quarter. Assenagon Asset Management S.A. increased its stake in Intuitive Surgical by 55.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after purchasing an additional 558,099 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Intuitive Surgical in the third quarter worth $136,743,000. Finally, Amundi raised its holdings in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after buying an additional 193,096 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $450.00 to $475.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Thursday. Finally, BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $439.89 on Friday. The company’s fifty day moving average price is $416.12 and its 200-day moving average price is $430.38. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The firm has a market capitalization of $152.48 billion, a P/E ratio of 53.19, a PEG ratio of 3.10 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.40 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,150 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total value of $529,000.00. Following the completion of the transaction, the director directly owned 1,150 shares of the company’s stock, valued at approximately $529,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares in the company, valued at $2,857,023.40. The trade was a 6.03% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 39,456 shares of company stock valued at $17,769,124. 0.60% of the stock is owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.